VANCOUVER, British Columbia, April 09, 2019 (GLOBE NEWSWIRE) -- Segra International Corp. (“Segra”), an agriculture technology company, is pleased to announce that it has appointed Jerry Kieran to the position of Executive Chairman. In this role, Mr. Kieran will contribute his expertise in the areas of business development, strategic pricing, and go-to-market strategies to bolster Segra’s position in the rapidly evolving global cannabis market.



“Jerry is a well-established thought leader and innovator in the cannabis space. It’s no surprise he has an intimate understanding of the value presented by our plant tissue culture technology,” stated Segra CEO Todd McMurray. “He shares our vision for accelerating the industry’s progress toward providing licensed producers with pathogen-free cannabis plantlets. His proven ability and focus on augmenting financial performance and mitigating risk for all stakeholders across the cannabis ecosystem made him the clear choice as Segra’s Executive Chairman.”

Mr. Kieran adds more than two decades of business development and horticulture experience to the Segra team. As the former Chief Business Development Officer for Fluence Bioengineering (“Fluence”), a global leader in horticultural lighting solutions, he was responsible for creating and executing the business strategies that fueled Fluence’s rapid growth. In 2018, Fluence was acquired by German lighting technology group Osram Licht AG.

“It’s been a privilege to partner with so many professionals across the Commercial Agriculture and Cannabis industry, and my sincere pleasure to help accelerate the convergence between these two industries,” said Mr. Kieran. “My journey continues with Segra and their many genetics partners as the cannabis industry shifts toward scale production and naturally embraces tissue culture. The benefits of tissue culture for the cannabis industry far outweigh those derived from widespread use within traditional Commercial Agriculture, and it is my pleasure to lend my talents to the incredible team at Segra, as we collaboratively explore the next frontier of optimized cultivation with our partners in cannabis.”

About Segra International

Segra is an agriculture technology company offering innovative services that accelerate the advancement of the cannabis industry to better serve society. The Company’s plant tissue culture and genomics technologies, coupled with an evolved cannabis business ecosystem, empower its clients to drive financial performance and mitigate risk, while exploring the next frontier of optimized cultivation practices for the rapidly evolving cannabis consumer. Segra is developing industrial-scale laboratories to produce disease-free, robust, and DNA-fingerprinted cannabis plantlets for licensed producers globally. To support this vision, Segra has assembled a world-class team of specialists in the fields of agronomy, molecular genetics, plant tissue culture, and regulatory compliance. Segra currently has agreements with many leading global cannabis producers, including the Canadian licensed producers HEXO Corp., Agripharm Corp., and The Supreme Cannabis Company Inc.

Forward-looking information

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

For further information, contact:

Sam Woolf